These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23810379)

  • 21. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.
    Huang-Doran I; Tomlinson P; Payne F; Gast A; Sleigh A; Bottomley W; Harris J; Daly A; Rocha N; Rudge S; Clark J; Kwok A; Romeo S; McCann E; Müksch B; Dattani M; Zucchini S; Wakelam M; Foukas LC; Savage DB; Murphy R; O'Rahilly S; Barroso I; Semple RK
    JCI Insight; 2016 Oct; 1(17):e88766. PubMed ID: 27766312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity.
    Tsay A; Wang JC
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
    Hofmann BT; Jücker M
    Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility.
    Di Zazzo E; Feola A; Zuchegna C; Romano A; Donini CF; Bartollino S; Costagliola C; Frunzio R; Laccetti P; Di Domenico M; Porcellini A
    ScientificWorldJournal; 2014; 2014():565839. PubMed ID: 25114970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short syndrome-an expanding phenotype.
    Singh A; Arora R; Singh P; Kapoor S
    Indian Pediatr; 2013 Apr; 50(4):414-6. PubMed ID: 23665600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-100-3p inhibits the adipogenic differentiation of hMSCs by targeting PIK3R1 via the PI3K/AKT signaling pathway.
    Wang T; Zhong D; Qin Z; He S; Gong Y; Li W; Li X
    Aging (Albany NY); 2020 Nov; 12(24):25090-25100. PubMed ID: 33221758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.
    Thorpe LM; Spangle JM; Ohlson CE; Cheng H; Roberts TM; Cantley LC; Zhao JJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7095-7100. PubMed ID: 28630349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.
    Lucas CL; Zhang Y; Venida A; Wang Y; Hughes J; McElwee J; Butrick M; Matthews H; Price S; Biancalana M; Wang X; Richards M; Pozos T; Barlan I; Ozen A; Rao VK; Su HC; Lenardo MJ
    J Exp Med; 2014 Dec; 211(13):2537-47. PubMed ID: 25488983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway.
    Turturro SB; Najor MS; Yung T; Portt L; Malarkey CS; Abukhdeir AM; Cobleigh MA
    Breast Cancer Res Treat; 2019 Sep; 177(2):325-333. PubMed ID: 31209687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase.
    Terauchi Y; Tsuji Y; Satoh S; Minoura H; Murakami K; Okuno A; Inukai K; Asano T; Kaburagi Y; Ueki K; Nakajima H; Hanafusa T; Matsuzawa Y; Sekihara H; Yin Y; Barrett JC; Oda H; Ishikawa T; Akanuma Y; Komuro I; Suzuki M; Yamamura K; Kodama T; Suzuki H; Yamamura K; Kodama T; Suzuki H; Koyasu S; Aizawa S; Tobe K; Fukui Y; Yazaki Y; Kadowaki T
    Nat Genet; 1999 Feb; 21(2):230-5. PubMed ID: 9988280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains.
    Lee JY; Chiu YH; Asara J; Cantley LC
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14157-62. PubMed ID: 21825134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of PIK3R1 gene variation induced SHORT syndrome].
    Cao BY; Wu D; Gong CX
    Zhonghua Er Ke Za Zhi; 2021 Mar; 59(3):228-230. PubMed ID: 33657699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
    Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
    Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p85alpha regulates osteoblast differentiation by cross-talking with the MAPK pathway.
    Wu X; Chen S; Orlando SA; Yuan J; Kim ET; Munugalavadla V; Mali RS; Kapur R; Yang FC
    J Biol Chem; 2011 Apr; 286(15):13512-21. PubMed ID: 21324896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma.
    Hauck F; Magg T; Krolo A; Bilic I; Hirschmugl T; Laass M; Rösen-Wolff A; Luksch H; Boztug K; Roesler J
    Klin Padiatr; 2017 May; 229(3):113-117. PubMed ID: 28561224
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action.
    Deng Y; Bhattacharya S; Swamy OR; Tandon R; Wang Y; Janda R; Riedel H
    J Biol Chem; 2003 Oct; 278(41):39311-22. PubMed ID: 12783867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Stariha JTB; Rathinaswamy MK; Powell CJ; Boulanger MJ; Burke JE
    Structure; 2020 Feb; 28(2):145-156.e5. PubMed ID: 31831213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K).
    Maeno Y; Li Q; Park K; Rask-Madsen C; Gao B; Matsumoto M; Liu Y; Wu IH; White MF; Feener EP; King GL
    J Biol Chem; 2012 Feb; 287(7):4518-30. PubMed ID: 22158866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.